Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Foreman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Oncology|June 17, 2020
Biosimilars in supportive careEmma Foreman
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
PrefaceEmma Foreman, Alexandre Chan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 14, 2020
Staff sensitisation to therapeutic monoclonal antibodies resulting from workplace exposure: A case reportLisa Barrott, Emma Foreman
British Journal of Clinical Pharmacology|April 26, 2022
Histamine-2 (H<sub>2</sub> ) antagonists can be safely removed from standard paclitaxel premedication regimensEmma Foreman, Calum Polwart, Andrew Walker, et al.
Age and Ageing|January 9, 2016
Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case reportGeoffrey Howard Wells, Louise D Mason, Emma Foreman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
BMC Nursing|November 9, 2022
'A life in a day' simulation experience: perceptions of oncology nurses and pharmacy staffRachel Ehibhatiomhan, Emma Foreman, Lisa Barrott, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2023
Multiple cardiotoxicities during osimertinib therapyHasan Kobat, Michael Davidson, Islam Elkonaissi, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 7, 2016
The physical health of Indigenous and non-Indigenous patients participating in residential rehabilitation programs: a comparison studyTom Meehan, Donna Jones, Terry Stedman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy PractitionersEmma Foreman, Himanshu Patel, Jim Siderov, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|June 17, 2020
Biosimilars in supportive careEmma Foreman
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
PrefaceEmma Foreman, Alexandre Chan
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 14, 2020
Staff sensitisation to therapeutic monoclonal antibodies resulting from workplace exposure: A case reportLisa Barrott, Emma Foreman
British Journal of Clinical Pharmacology|April 26, 2022
Histamine-2 (H<sub>2</sub> ) antagonists can be safely removed from standard paclitaxel premedication regimensEmma Foreman, Calum Polwart, Andrew Walker, et al.
Age and Ageing|January 9, 2016
Continuous subcutaneous levetiracetam in the management of seizures at the end of life: a case reportGeoffrey Howard Wells, Louise D Mason, Emma Foreman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
Assessing biosimilar education needs among oncology pharmacy practitioners worldwide: An ISOPP membership surveyAlexandre Chan, Himanshu Patel, Jim Siderov, et al.
BMC Nursing|November 9, 2022
'A life in a day' simulation experience: perceptions of oncology nurses and pharmacy staffRachel Ehibhatiomhan, Emma Foreman, Lisa Barrott, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 21, 2023
Multiple cardiotoxicities during osimertinib therapyHasan Kobat, Michael Davidson, Islam Elkonaissi, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 7, 2016
The physical health of Indigenous and non-Indigenous patients participating in residential rehabilitation programs: a comparison studyTom Meehan, Donna Jones, Terry Stedman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 10, 2020
A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy PractitionersEmma Foreman, Himanshu Patel, Jim Siderov, et al.
Pageof 2